Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07806227) titled 'Broadband Near Infrared Spectroscopy to Understand the Role of Brain Cytochrome C Oxidase in Bipolar Disorder' on Sept. 2.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Martin Lan
Condition:
Bipolar Disorder Depression
Intervention:
Drug: Lurasidone (Latuda)
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: November 1, 2026
Target Sample Size: 60
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT078062...